Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sarkola, T.
Right arrow Articles by Helander, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sarkola, T.
Right arrow Articles by Helander, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Alcohol and Alcoholism Vol. 38, No. 4, pp. 347-351, 2003
© 2003 Medical Council on Alcohol

URINARY ETHYL GLUCURONIDE AND 5-HYDROXYTRYPTOPHOL LEVELS DURING REPEATED ETHANOL INGESTION IN HEALTHY HUMAN SUBJECTS

Taisto Sarkola, Helen Dahl1, C. J. Peter Eriksson and Anders Helander1,*

Department of Mental Health and Alcohol Research, National Public Health Institute, POB 33, FIN-00251 Helsinki, Finland and
1 Department of Clinical Neuroscience, Karolinska Institutet, SE-171 76 Stockholm, Sweden

Received 21 October 2002; in revised form 3 February 2003; in revised form 12 February 2003; accepted 12 March 2003

Aims: This study investigated the stability and reproducibility of urinary ethyl glucuronide (EtG) and the 5-hydroxytryptophol (5-HTOL) to 5-hydroxyindole-3-acetic acid (5-HIAA) ratio, both of which are used as biochemical markers of recent alcohol consumption, after single and multiple oral doses of ethanol in healthy human subjects. Methods: Nine females aged 19–27 years drank ethanol (8%, w/v, in juice) or placebo (juice) in random order. The intervention consisted of 0.4 g/kg (22–28 g) of ethanol or placebo twice daily (in the morning and evening) during 8 consecutive days, starting in the evening on day 1. Spot urine samples of the first morning void were collected during the 8-day drinking period and for another 3 days (days 9–11) with no intake of ethanol or placebo. Ethanol, EtG, 5-HTOL and 5-HIAA were determined in the urine samples by headspace GC, LC–MS, GC–MS and HPLC, respectively. Results: The individual results during the drinking period were highly variable, both within and between subjects, ranging from 0–7.3 mmol/l for ethanol, 1.4–71.0 mg/l for EtG, 0.1–4.5 mg/mmol for the EtG/creatinine ratio, and 2–109 nmol/µmol for 5-HTOL/5-HIAA. The placebo group consistently showed negative values for ethanol (< 0.1 mmol/l) and 5-HTOL/5-HIAA (< 15 nmol/µmol), but two samples were positive for EtG (> 0.1 mg/l). In the morning of day 9 (i.e. ~14–15 h after the last dose), ethanol was no longer measurable in urine and the 5-HTOL/5-HIAA ratio had returned to below the reference value, but detectable levels of EtG (11.3 ± 6.0 mg/l, mean ± SD) and the EtG/creatinine ratio (1.0 ± 0.3 mg/mmol) were found in all samples. Conclusions: The results confirm the increase in urinary EtG and 5-HTOL levels during acute ethanol intake, although the individual values were highly variable both within and between subjects. No significant accumulation of either compound occurred upon multiple-dose administration of 0.8 g/kg (44–57 g) ethanol per day for ~1 week.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Alcohol AlcoholHome page
G. Hoiseth, J. P. Bernard, N. Stephanson, P. T. Normann, A. S. Christophersen, J. Morland, and A. Helander
Comparison between the urinary alcohol markers EtG, EtS, and GTOL/5-HIAA in a controlled drinking experiment
Alcohol Alcohol., March 1, 2008; 43(2): 187 - 191.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
O. Beck, N. Stephanson, M. Bottcher, N. Dahmen, C. Fehr, and A. Helander
Biomarkers to disclose recent intake of alcohol: potential of 5-hydroxytryptophol glucuronide testing using new direct UPLC-tandem MS and ELISA methods
Alcohol Alcohol., July 1, 2007; 42(4): 321 - 325.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.